The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
A Selective Imidazobenzodiazepine Antagonist of Ethanol in the Rat
Abstract
Ethanol, at pharmacologically relevant concentrations of 20 to 100 mM, stimulates γ-aminobutyric (GABA) receptor-mediated uptake of 36 Cl-labeled chlorine into isolated brain vesicles. One drug that acts at GABA-benzodiazepine receptors, the imidazobenzodiazepine Ro15-4513, has been found to be a potent antagonist of ethanol-stimulated 36 Cl - uptake into brain vesicles, but it fails to antagonize either pentobarbital- or muscimol-stimulated 36 Cl - uptake. Pretreatment of rats with Ro15-4513 blocks the anticonflict activity of low doses of ethanol (but not pentobarbital) as well as the behavioral intoxication observed with higher doses of ethanol. The effects of Ro15-4513 in antagonizing ethanol-stimulated 36 Cl - uptake and behavior are completely blocked by benzodiazepine receptor antagonists. However, other benzodiazepine receptor inverse agonists fail to antagonize the actions of ethanol in vitro or in vivo, suggesting a novel interaction of Ro15-4513 with the GABA receptor-coupled chloride ion channel complex. The identification of a selective benzodiazepine antagonist of ethanol-stimulated 36 Cl - uptake in vitro that blocks the anxiolytic and intoxicating actions of ethanol suggests that many of the neuropharmacologic actions of ethanol may be mediated via central GABA receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective antagonists of benzodiazepines
Hunkeler, W., Möhler, H., Pieri, L., Polc, P., Bonetti, E. P., Cumin, R., Schaffner, R., & Haefely, W. (1981) · Nature · doi:10.1038/290514a0 · Cited by 1,232
GABA‐Benzodiazepine‐Barbiturate Receptor Interactions
Olsen, R. W. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb05284.x · Cited by 894
Receptors for the Age of Anxiety: Pharmacology of the Benzodiazepines
Tallman, J. F., Paul, S. M., Skolnick, P., & Gallager, D. W. (1980) · Science · doi:10.1126/science.6101294 · Cited by 862
Self-citationA simple and reliable conflict procedure for testing anti-anxiety agents
Vogel, J. R., Beer, B., & Clody, D. E. (1971) · Psychopharmacologia · doi:10.1007/bf00403989 · Cited by 841
Induction of physical dependence upon ethanol and the associated behavioral changes in rats
Majchrowicz, E. (1975) · Psychopharmacologia · doi:10.1007/bf00429258 · Cited by 738
DRUG INTERACTIONS AT THE GABA RECEPTOR-IONOPHORE COMPLEX
Olsen, R. W. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.001333 · Cited by 695
Study, R. E., & Barker, J. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.7180 · Cited by 561
Suzdak, P. D., Schwartz, R. D., Skolnick, P., & Paul, S. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.11.4071 · Cited by 539
Self-citationNew concepts on the mechanism of action of benzodiazepines
Costa, E., Guidotti, A., Mao, C. C., & Suria, A. (1975) · Life Sciences · doi:10.1016/0024-3205(75)90501-9 · Cited by 536
CHIN, J. H., & GOLDSTEIN, D. B. (1977) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11220-0 · Cited by 459
Cited by
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
(1987) · Recent Developments in Alcoholism · doi:10.1007/978-1-4899-1684-6 · Cited by 1,038
Neuropsychology and neuropharmacology of P3a and P3b
Polich, J., & Criado, J. R. (2006) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2005.12.012 · Cited by 741
Effects of Moderate Alcohol Consumption on the Central Nervous System*
Eckardt, M. J., File, S. E., Gessa, G. L., Grant, K. A., Guerri, C., Hoffman, P. L., Kalant, H., Koob, G. F., Li, T., & Tabakoff, B. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03695.x · Cited by 622
Neural Mechanisms of Drug Reinforcementa
KOOB, G. F. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25966.x · Cited by 610
The neurobiology of drug addiction
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.482 · Cited by 562
Cerebellar GABAA receptor selective for a behavioural alcohol antagonist
Lüddens, H., Pritchett, D. B., Köhler, M., Killisch, I., Keinänen, K., Monyer, H., Sprengel, R., & Seeburg, P. H. (1990) · Nature · doi:10.1038/346648a0 · Cited by 538
Hevers, W., & Lüddens, H. (1998) · Molecular Neurobiology · doi:10.1007/bf02741459 · Cited by 489
The role of GABA A receptors in the acute and chronic effects of ethanol
Grobin, A. C., Matthews, D. B., Devaud, L. L., & Morrow, A. L. (1998) · Psychopharmacology · doi:10.1007/s002130050685 · Cited by 472
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
Ethanol and the Nervous System
Charness, M. E., Simon, R. P., & Greenberg, D. A. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908173210706 · Cited by 356
GABAA receptor: Positive and negative allosteric modulators
Olsen, R. W. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.036 · Cited by 354
Cagetti, E., Liang, J., Spigelman, I., & Olsen, R. W. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.53 · Cited by 320
VanDoren, M. J., Matthews, D. B., Janis, G. C., Grobin, A. C., Devaud, L. L., & Morrow, A. L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01982.2000 · Cited by 313
Alcohol-induced motor impairment caused by increased extrasynaptic GABAA receptor activity
Hanchar, H. J., Dodson, P. D., Olsen, R. W., Otis, T. S., & Wallner, M. (2005) · Nature Neuroscience · doi:10.1038/nn1398 · Cited by 307
Ion Channels in Presynaptic Nerve Terminals and Control of Transmitter Release
Meir, A., Ginsburg, S., Butkevich, A., Kachalsky, S. G., Kaiserman, I., Ahdut, R., Demirgoren, S., & Rahamimoff, R. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.3.1019 · Cited by 300
Effects of Ethanol on Ion Channels
Crews, F. T., Morrow, A. L., Criswell, H., & Breese, G. (1996) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60670-4 · Cited by 299
Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats
McBride, W. J., Murphy, J. M., Lumeng, L., & Li, T.-K. (1990) · Alcohol · doi:10.1016/0741-8329(90)90005-w · Cited by 297
Bräse, S., Gil, C., & Knepper, K. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00025-1 · Cited by 280
GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME
Gallimberti, L., Gentile, N., Cibin, M., Fadda, F., Canton, G., Ferri, M., Ferrara, S. D., & Gessa, G. L. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90842-8 · Cited by 266
Ethanol and neurotransmitter interactions—from molecular to integrative effects
Faingold, C. L., N'Gouemo, P., & Riaz, A. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00027-6 · Cited by 265
Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels
Allan, A. M., & Harris, R. A. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90192-4 · Cited by 264
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism
Nevo, I. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00139-l · Cited by 263
Behavioral Pharmacology of Zolpidem Relative to Benzodiazepines A Review
Rush, C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00102-6 · Cited by 260
Regulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
McNaughton, N., Kocsis, B., & Hajós, M. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee82e3 · Cited by 187
“The effects of ethanol have been challenged with the partial benzodiazepine inverse agonist Ro 15-4513 which appears to be a selective ethanol antagonist (Suzdak et al., 1986).”
BackgroundGABAA receptor subtypes: the ‘one glass of wine’ receptors
Olsen, R. W., Hanchar, H. J., Meera, P., & Wallner, M. (2007) · Alcohol · doi:10.1016/j.alcohol.2007.04.006 · Cited by 142
“In addition, some laboratories showed that a biochemical GABAAR assay, using 36Cl− flux in cell-free membrane homogenates, sometimes called synptoneurosomes, is increased by relevant low doses of ethanol (Suzdak et al., 1986a; Allan and Harris, 1987).”
BackgroundResultKlein, R. L., & Harris, R. A. (1996) · Japanese Journal of Pharmacology · doi:10.1254/jjp.70.1 · Cited by 41
Brouillet, E., Chavoix, C., Bottlaender, M., Khalili-Varasteh, M., Hantraye, P., Fournier, D., Dodd, R. H., & Mazière, M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90131-e · Cited by 37
Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome
Potier, M.-C., Braudeau, J., Dauphinot, L., & Delatour, B. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660185 · Cited by 34
“Ro15-4513 a partial inverse agonist developed by Hoffmann-La Roche has been used for blocking the effects of ethanol in the central nervous system [35].”
MethodNeurosteroid influences on sensitivity to ethanol
Helms, C. M., Rossi, D. J., & Grant, K. A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00010 · Cited by 30
Metadata
- Authors
- Suzdak, P. D., Glowa, J. R., Crawley, J. N., Schwartz, R. D., Skolnick, P., & Paul, S. M.
- Venue
- Science
- Published
- 1986-12-05
- Volume
- 234
- Issue
- 4781
- Pages
- 1243-1247
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2028650350
- Cited by
- 543
- References
- 33
- FWCI
- 21.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.